On the other hand, 16 patients were diagnosed with EGFR T790M mutation from the tumor samples by both PANAMutyper and cobas v2 but did not receive osimertinib treatment, including three patients who had early-stage disease without progression and 13 patients with late stage disease. This evidence concerns the gene EGFR and neoplasm.